Checks and balances: interplay of RTKs and PTPs in cancer progression.

In recent years, targeted therapies for receptor tyrosine kinases (RTKs) have shown initial promise in the clinical setting for the treatment of several tumors driven by these oncogenic signaling pathways. Unfortunately, clinical relapse due to acquired resistance to these molecular therapeutics is common. An improved understanding of how tumors bypass the inhibitory effects of RTK-targeted therapies has revealed a rich myriad of possible mechanisms for acquired resistance. Protein tyrosine phosphatases (PTPs) can function as oncogenes or tumor suppressors to either enhance or suppress RTK signaling. Recent studies suggest that the loss or gain of function of PTP's can significantly impinge on RTK signaling during tumor progression. Here we review the interplay between RTKs and PTPs as an emerging mechanism for acquired resistance to RTK-targeted therapies, that may aid in the design of improved therapies to prevent and overcome resistance in treatments for cancer patients.

[1]  E. Schaefer,et al.  Inhibition of the Catalytic Activity of Cell Adhesion Kinase β by Protein-tyrosine Phosphatase-PEST-mediated Dephosphorylation* , 2001, The Journal of Biological Chemistry.

[2]  Keara M. Lane,et al.  Impaired SHP2-mediated extracellular signal-regulated kinase activation contributes to gefitinib sensitivity of lung cancer cells with epidermal growth factor receptor-activating mutations. , 2010, Cancer research.

[3]  J. Lilien,et al.  The Nonreceptor Protein Tyrosine Phosphatase PTP1B Binds to the Cytoplasmic Domain of N-Cadherin and Regulates the Cadherin–Actin Linkage , 1998, The Journal of cell biology.

[4]  John D. Minna,et al.  Activating Mutations of the Noonan Syndrome-Associated SHP2/PTPN11 Gene in Human Solid Tumors and Adult Acute Myelogenous Leukemia , 2004, Cancer Research.

[5]  S. Hardy,et al.  Caspase-3 Regulates Catalytic Activity and Scaffolding Functions of the Protein Tyrosine Phosphatase PEST, a Novel Modulator of the Apoptotic Response , 2006, Molecular and Cellular Biology.

[6]  A. Saltiel,et al.  Protein-tyrosine-phosphatase SHPTP2 is a required positive effector for insulin downstream signaling. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[7]  T. Han,et al.  Ptpn11/Shp2 acts as a tumor suppressor in hepatocellular carcinogenesis. , 2011, Cancer cell.

[8]  E. Chevet,et al.  Protein-tyrosine Phosphatase 1B Potentiates IRE1 Signaling during Endoplasmic Reticulum Stress* , 2004, Journal of Biological Chemistry.

[9]  F. Haj,et al.  Altered Glucose Homeostasis in Mice with Liver-specific Deletion of Src Homology Phosphatase 2* , 2010, The Journal of Biological Chemistry.

[10]  Z. Chang,et al.  Regulation of RhoA-dependent ROCKII activation by Shp2 , 2008, The Journal of cell biology.

[11]  M. Westwood,et al.  The protein-tyrosine phosphatase, SRC homology-2 domain containing protein tyrosine phosphatase-2, is a crucial mediator of exogenous insulin-like growth factor signaling to human trophoblast. , 2009, Endocrinology.

[12]  B. Cho,et al.  Acquired resistance to cetuximab is mediated by increased PTEN instability and leads cross-resistance to gefitinib in HCC827 NSCLC cells. , 2010, Cancer letters.

[13]  B. Kennedy,et al.  Protein tyrosine phosphatase 1B deficiency or inhibition delays ErbB2-induced mammary tumorigenesis and protects from lung metastasis , 2007, Nature Genetics.

[14]  M. Tremblay,et al.  Protein Tyrosine Phosphatase-PEST Regulates Focal Adhesion Disassembly, Migration, and Cytokinesis in Fibroblasts , 1999, The Journal of cell biology.

[15]  B. Neel,et al.  The tyrosine phosphatase Shp2 (PTPN11) in cancer , 2008, Cancer and Metastasis Reviews.

[16]  G. Feng,et al.  Role of Gab2 in mammary tumorigenesis and metastasis , 2007, Oncogene.

[17]  B. Neel,et al.  Receptor-Specific Regulation of Phosphatidylinositol 3′-Kinase Activation by the Protein Tyrosine Phosphatase Shp2 , 2002, Molecular and Cellular Biology.

[18]  Luis E. Arias-Romero,et al.  Activation of Src by protein tyrosine phosphatase 1B Is required for ErbB2 transformation of human breast epithelial cells. , 2009, Cancer research.

[19]  L. Shaw,et al.  SHP2 Mediates the Localized Activation of Fyn Downstream of the α6β4 Integrin To Promote Carcinoma Invasion , 2010, Molecular and Cellular Biology.

[20]  P. Jänne,et al.  Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non–Small Cell Lung Cancer , 2009, Clinical Cancer Research.

[21]  B. Evers,et al.  PTP-PEST controls motility, adherens junction assembly, and Rho GTPase activity in colon cancer cells. , 2010, American journal of physiology. Cell physiology.

[22]  Y. Agazie,et al.  Inhibition of SHP2 leads to mesenchymal to epithelial transition in breast cancer cells , 2008, Cell Death and Differentiation.

[23]  S. K. Shore,et al.  SRC in human carcinogenesis. , 2003, Frontiers in bioscience : a journal and virtual library.

[24]  C. Hellberg,et al.  Protein-tyrosine phosphatases and cancer , 2006, Nature Reviews Cancer.

[25]  M. Tremblay,et al.  PTP-PEST Couples Membrane Protrusion and Tail Retraction via VAV2 and p190RhoGAP* , 2006, Journal of Biological Chemistry.

[26]  G. Mills,et al.  Acquired resistance to erlotinib in A-431 epidermoid cancer cells requires down-regulation of MMAC1/PTEN and up-regulation of phosphorylated Akt. , 2007, Cancer research.

[27]  S. Goff,et al.  Cytoskeletal protein PSTPIP1 directs the PEST-type protein tyrosine phosphatase to the c-Abl kinase to mediate Abl dephosphorylation. , 2000, Molecular cell.

[28]  Michael D Schaller,et al.  Cellular functions of FAK kinases: insight into molecular mechanisms and novel functions , 2010, Journal of Cell Science.

[29]  S. Hardy,et al.  Inside the human cancer tyrosine phosphatome , 2010, Nature Reviews Cancer.

[30]  N. Tonks,et al.  Association of PTP-PEST with the SH3 domain of p130cas; a novel mechanism of protein tyrosine phosphatase substrate recognition , 1997, Oncogene.

[31]  Andrea Richardson,et al.  A role for the scaffolding adapter GAB2 in breast cancer , 2006, Nature Medicine.

[32]  M. Tremblay,et al.  The role of protein tyrosine phosphatase 1B in Ras signaling , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[33]  M. Mann,et al.  The Phosphotyrosine Interactome of the Insulin Receptor Family and Its Substrates IRS-1 and IRS-2*S , 2009, Molecular & Cellular Proteomics.

[34]  J. Iovanna,et al.  ArgBP2-dependent signaling regulates pancreatic cell migration, adhesion, and tumorigenicity. , 2008, Cancer research.

[35]  A. Wilks.  The JAK kinases: not just another kinase drug discovery target. , 2008, Seminars in cell & developmental biology.

[36]  T. Hunter.  Tyrosine phosphorylation: thirty years and counting. , 2009, Current opinion in cell biology.

[37]  F. Haj,et al.  Regulation of protein tyrosine phosphatase 1B by sumoylation , 2007, Nature Cell Biology.

[38]  Lorena Rossi,et al.  Modification of miR gene expression pattern in human colon cancer cells following exposure to 5-fluorouracil in vitro. , 2007, Pharmacological research.

[39]  M. Tremblay,et al.  PTP1B and TC-PTP: regulators of transformation and tumorigenesis , 2008, Cancer and Metastasis Reviews.

[40]  M. Rao,et al.  Activation of Multiple Proto-oncogenic Tyrosine Kinases in Breast Cancer via Loss of the PTPN12 Phosphatase , 2011, Cell.

[41]  F. Liu,et al.  Protein tyrosine phosphatase 1B negatively regulates integrin signaling , 1998, Current Biology.

[42]  G. Feng,et al.  Protein-tyrosine Phosphatase Shp-2 Regulates Cell Spreading, Migration, and Focal Adhesion* , 1998, The Journal of Biological Chemistry.

[43]  J. Chernoff,et al.  Protein tyrosine phosphatase 1B interacts with and is tyrosine phosphorylated by the epidermal growth factor receptor. , 1997, The Biochemical journal.

[44]  R. Bast,et al.  Overexpression of the tyrosine phosphatase PTP1B is associated with human ovarian carcinomas. , 1994, American journal of obstetrics and gynecology.

[45]  R. Bast,et al.  Overexpression of the protein tyrosine phosphatase PTP1B in human breast cancer: association with p185c-erbB-2 protein expression. , 1994, Journal of the National Cancer Institute.

[46]  M. Schaller,et al.  The Noncatalytic Domain of Protein-tyrosine Phosphatase-PEST Targets Paxillin for Dephosphorylation in Vivo * , 2000, The Journal of Biological Chemistry.

[47]  Veena Sangwan,et al.  Protein-tyrosine Phosphatase 1B Deficiency Protects against Fas-induced Hepatic Failure* , 2006, Journal of Biological Chemistry.

[48]  Ha Won Kim,et al.  Role of Protein Tyrosine Phosphatase 1B in Vascular Endothelial Growth Factor Signaling and Cell–Cell Adhesions in Endothelial Cells , 2008, Circulation research.

[49]  B. Franza,et al.  Protein Tyrosine Phosphatase 1B Antagonizes Signalling by Oncoprotein Tyrosine Kinase p210 bcr-abl In Vivo , 1998, Molecular and Cellular Biology.

[50]  D. Robinson,et al.  The protein tyrosine kinase family of the human genome , 2000, Oncogene.

[51]  L. Lessard,et al.  The two faces of PTP1B in cancer. , 2010, Biochimica et biophysica acta.

[52]  M. White,et al.  IRS proteins and the common path to diabetes. , 2002, American journal of physiology. Endocrinology and metabolism.

[53]  J. Bjorge,et al.  PTP1B contributes to the oncogenic properties of colon cancer cells through Src activation. , 2007, Cancer research.

[54]  J. Crawford,et al.  Activation of tyrosine kinases in cancer. , 2003, The oncologist.

[55]  L. Trusolino,et al.  β4 integrin activates a Shp2–Src signaling pathway that sustains HGF-induced anchorage-independent growth , 2006, The Journal of cell biology.

[56]  M. Schaller,et al.  PTP-PEST controls motility through regulation of Rac1 , 2002, Journal of Cell Science.

[57]  Yuan Ren,et al.  Critical role of Shp2 in tumor growth involving regulation of c-Myc. , 2010, Genes & cancer.

[58]  Jie Wu,et al.  Targeting protein tyrosine phosphatases for anticancer drug discovery. , 2010, Current pharmaceutical design.

[59]  S. Polo,et al.  Endocytosis Conducts the Cell Signaling Orchestra , 2006, Cell.

[60]  B. Franza,et al.  Multi‐site phosphorylation of the protein tyrosine phosphatase, PTP1B: identification of cell cycle regulated and phorbol ester stimulated sites of phosphorylation. , 1993, The EMBO journal.

[61]  A. Ullrich,et al.  PTP-PEST phosphatase variations in human cancer. , 2006, Cancer genetics and cytogenetics.

[62]  Ming Tan,et al.  PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients. , 2004, Cancer cell.

[63]  B. Neel,et al.  Protein-tyrosine phosphatase 1B is required for HER2/Neu-induced breast cancer. , 2007, Cancer research.

[64]  N. Tonks,et al.  Regulation of Fibroblast Motility by the Protein Tyrosine Phosphatase PTP-PEST* , 1999, The Journal of Biological Chemistry.

[65]  K. Aldape,et al.  FAK phosphorylation by ERK primes ras-induced tyrosine dephosphorylation of FAK mediated by PIN1 and PTP-PEST. , 2009, Molecular cell.

[66]  M. Hatakeyama.  Oncogenic mechanisms of the Helicobacter pylori CagA protein , 2004, Nature Reviews Cancer.

[67]  A. Yoshimura,et al.  Reduction of PTEN protein and loss of epidermal growth factor receptor gene mutation in lung cancer with natural resistance to gefitinib (IRESSA) , 2005, British Journal of Cancer.

[68]  B. Blagoev,et al.  PTP1B Targets the Endosomal Sorting Machinery , 2010, The Journal of Biological Chemistry.

[69]  W. Hofmann,et al.  Inhibition of Phosphotyrosine Phosphatase 1B Causes Resistance in BCR-ABL-Positive Leukemia Cells to the ABL Kinase Inhibitor STI571 , 2006, Clinical Cancer Research.

[70]  Y. Radhakrishnan,et al.  Identification of Novel SHPS-1-associated Proteins and Their Roles in Regulation of Insulin-like Growth Factor-dependent Responses in Vascular Smooth Muscle Cells* , 2009, Molecular & Cellular Proteomics.

[71]  A. Huttenlocher,et al.  Calpain 2 and PTP1B function in a novel pathway with Src to regulate invadopodia dynamics and breast cancer cell invasion , 2008, The Journal of cell biology.

[72]  M. Foti,et al.  Non-genomic loss of PTEN function in cancer: not in my genes. , 2011, Trends in pharmacological sciences.

[73]  L. Tan,et al.  Potential Molecular Mechanism for c-Src Kinase-mediated Regulation of Intestinal Cell Migration* , 2008, Journal of Biological Chemistry.

[74]  M. Tremblay,et al.  In control at the ER: PTP1B and the down-regulation of RTKs by dephosphorylation and endocytosis. , 2010, Trends in cell biology.

[75]  M. Tremblay,et al.  Essential function of PTP-PEST during mouse embryonic vascularization, mesenchyme formation, neurogenesis and early liver development , 2006, Mechanisms of Development.

[76]  M. Tremblay,et al.  Coupling of the murine protein tyrosine phosphatase PEST to the epidermal growth factor (EGF) receptor through a Src homology 3 (SH3) domain-mediated association with Grb2 , 1997, Oncogene.

[77]  S. Giordano,et al.  ReviewMolecular mechanisms of acquired resistance to tyrosine kinase targeted therapy , 2015 .

[78]  M. Hayman,et al.  Molecular Mechanism for a Role of SHP2 in Epidermal Growth Factor Receptor Signaling , 2003, Molecular and Cellular Biology.

[79]  Roger J Daly,et al.  Increased Proliferation and Altered Growth Factor Dependence of Human Mammary Epithelial Cells Overexpressing the Gab2 Docking Protein* , 2006, Journal of Biological Chemistry.